COMMUNIQUÉS West-GlobeNewswire

Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
14/08/2025
BOSTON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of [...]
Range Impact Reports 2Q 2025 Financial Results
14/08/2025
Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in [...]
BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025
14/08/2025
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ended June 30, 2025 on [...]
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
14/08/2025
AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs [...]
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
14/08/2025
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of [...]
Regional Health Properties, Inc. and SunLink Health Systems, Inc. Complete Merger
14/08/2025
Atlanta, GA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) today announced the completion of the merger of SunLink Health Systems, Inc. (“SunLink”) with and [...]
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026
14/08/2025
Submitted two additional U.S. government funding proposals during the quarter, bringing the total proposals to US$137 million Accepted as a new member of U.S. Medical CBRN Defense Consortium, strengthening government [...]
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
14/08/2025
COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq , while retaining the Company’s listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI [...]
INVO Fertility Announces Second Quarter 2025 Financial Results
14/08/2025
SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through [...]
Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH
15/08/2025
Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc [...]
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
14/08/2025
WARREN, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), today issued the following statement from Ryan Saadi, M.D., M.P.H., Founder and CEO. “Tevogen is an [...]
Heald Launches First Money-Back Guarantee in Digital Diabetes Reversal
14/08/2025
Patients see measurable A1C improvement in 90-120 days or get a full refund ALPHARETTA, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Heald, a pioneering digital health company specializing in Type 2 diabetes reversal through [...]
Ligand Announces Closing of Convertible Senior Notes Offering
14/08/2025
JUPITER, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today that it completed its previously announced offering (the “offering”) of 0.75% convertible [...]
Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress
14/08/2025
Conference call today, August 14, 2025, at 4:30 PM ET SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We [...]
MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities
14/08/2025
Newly-appointed President and CEO, Eric Risser, outlines strategic priorities for 2025 and 2026 Received $70 million upfront cash payment from Sagard Healthcare Partners under a royalty purchase agreement for ZYNYZ ® [...]
Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
14/08/2025
Patient dosing ongoing in CALiPSO-1 trial; on track to report clinical data for CNTY-101 in patients with B-cell-mediated autoimmune diseases by year-end 2025 CNTY-308, a CAR-iT cell therapy functionally comparable to [...]
Daré Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update
14/08/2025
DARE to PLAY™ Sildenafil Cream on Track for Q4 2025 Launch via 503B Compounding Pathway; Positioned for Product Revenue Beginning in Q4 2025 Positive Interim DSMB Outcome for Ovaprene® Phase 3 Study Supports Continued [...]
Celcuity Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
14/08/2025
Reported statistically significant and clinically meaningful improvement in both primary endpoints from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial Hazard ratios and improvements in median progression- [...]
U.S. Oral Surgery Management Moves into 31st State
14/08/2025
Announces Four New Partner Practices IRVING, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial [...]

Pages